EU Medical Device Tracking Requirements
This whitepaper provides an in-depth look at the European Union Medical Device Regulation, the EUDAMED database, key compliance milestones, Unique Device Identification requirements, and practical guidance to help manufacturers prepare.
It also outlines best practices for data readiness, system integration, and stakeholder alignment, while showing how SCW supports end-to-end compliance, hub connectivity, and digital transformation across medical device operations.
What this whitepaper covers
A practical overview of the regulatory landscape and the actions teams should prioritize now.
- EU MDR and EUDAMED explained in practical terms
- Key milestones across 2025, 2026, and beyond
- UDI labeling and direct marking deadlines by device class
- Readiness actions for data, systems, and governance
- How to reduce compliance friction before EUDAMED becomes mandatory
EU MDR and EUDAMED in context
The EU Medical Device Regulation, Regulation (EU) 2017/745, replaced the earlier Medical Device Directive and significantly strengthened requirements for device safety, post-market surveillance, and traceability. A major part of that shift is the introduction of UDI and the development of EUDAMED as the central European database for medical devices.
EUDAMED is designed to integrate multiple regulatory activities into one platform, including actor registration, device registration, certificates, vigilance, clinical investigations, and market surveillance. Even though not all modules are fully live yet, manufacturers are still expected to comply with MDR requirements now and prepare for mandatory use as the system becomes fully functional.
The six EUDAMED modules
- Actor Registration
- UDI and Device Registration
- Notified Bodies and Certificates
- Clinical Investigations and Performance Studies
- Vigilance and Post-Market Surveillance
- Market Surveillance
Why this matters operationally
- Protects market access across EU member states
- Improves traceability and transparency
- Strengthens readiness for audits and inspections
- Supports faster data exchange and regulatory alignment
- Reduces risk created by fragmented manual processes
Key takeaway: EUDAMED may still be transitioning toward full functionality, but MDR obligations are already real. Waiting for the final go-live date is not a low-risk strategy.
Timeline and key milestones
Understanding the timeline helps manufacturers plan system changes, data preparation, and internal ownership before deadlines become urgent. Based on the current page content, 2025 and 2026 are the key years in which EUDAMED shifts from a voluntary pathway toward an enforced operational reality.
EU MDR was adopted, introducing stricter requirements for clinical evidence, post-market surveillance, traceability, UDI, and EUDAMED.
EUDAMED development advanced and the first module, Actor Registration, became operational on a voluntary basis, allowing economic operators to begin registration and obtain SRNs.
The current outlook on the live page indicates the completed modules are expected to be audited by late 2025, creating the path toward an official declaration of functionality.
Once the database is officially declared functional, a six-month countdown begins before mandatory use of the core modules. This creates a narrow window for organizations that are still underprepared.
By 2027, the expectation is that all six modules will be operational, with the UDI implementation milestones fully completed across device classes.
UDI implementation deadlines
The MDR introduced phased implementation of UDI on product labeling and, for certain reusable devices, direct part marking. These compliance dates vary by device class and are central to readiness planning.
Label UDI deadlines
- May 26, 2021 for Class III and implantable devices
- May 26, 2023 for Class IIa and IIb devices
- May 26, 2025 for Class I devices
Direct marking deadlines
- May 26, 2023 for reusable Class III and implantable devices
- May 26, 2025 for reusable Class IIa and IIb devices
- May 26, 2027 for reusable Class I devices
These milestones matter because UDI is not a side requirement. It is the foundation for device traceability inside EUDAMED, and regulators, healthcare providers, and market authorities depend on it to identify and track products correctly.
What manufacturers should do now
The strongest preparation programs focus on more than labeling changes. They address the underlying data and process foundations needed to support ongoing compliance as EUDAMED becomes mandatory.
Prioritize data readiness
- Validate device master data and UDI structures
- Confirm registration data is complete and governed
- Standardize ownership for updates and corrections
- Align data across regulatory, quality, and supply chain teams
Strengthen systems and operating model
- Review readiness for hub and database connectivity
- Map internal workflows for submission and updates
- Clarify stakeholder roles across quality, regulatory, and operations
- Reduce manual handoffs that create compliance delay
Practical point: The companies that move fastest when mandatory use begins will be the ones that already solved the operational basics: trusted data, aligned ownership, and integration readiness.
Need help preparing for EU MDR tracking requirements?
SCW helps organizations strengthen traceability, prepare device data, support EUDAMED readiness, and design the processes and integrations needed for sustainable compliance.
